IBDEI10S ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16585,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,16585,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,16586,0)
 ;;=C90.00^^61^775^178
 ;;^UTILITY(U,$J,358.3,16586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16586,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,16586,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,16586,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,16587,0)
 ;;=C94.6^^61^775^179
 ;;^UTILITY(U,$J,358.3,16587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16587,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,16587,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,16587,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,16588,0)
 ;;=D61.82^^61^775^180
 ;;^UTILITY(U,$J,358.3,16588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16588,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,16588,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,16588,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,16589,0)
 ;;=D47.9^^61^775^181
 ;;^UTILITY(U,$J,358.3,16589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16589,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,16589,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,16589,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,16590,0)
 ;;=D53.9^^61^775^185
 ;;^UTILITY(U,$J,358.3,16590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16590,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16590,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,16590,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,16591,0)
 ;;=D47.4^^61^775^186
 ;;^UTILITY(U,$J,358.3,16591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16591,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,16591,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,16591,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,16592,0)
 ;;=D51.3^^61^775^210
 ;;^UTILITY(U,$J,358.3,16592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16592,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,16592,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,16592,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,16593,0)
 ;;=D77.^^61^775^62
 ;;^UTILITY(U,$J,358.3,16593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16593,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,16593,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,16593,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,16594,0)
 ;;=D58.2^^61^775^88
 ;;^UTILITY(U,$J,358.3,16594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16594,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,16594,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,16594,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,16595,0)
 ;;=C88.8^^61^775^110
 ;;^UTILITY(U,$J,358.3,16595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16595,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,16595,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,16595,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,16596,0)
 ;;=D70.8^^61^775^183
 ;;^UTILITY(U,$J,358.3,16596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16596,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,16596,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,16596,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,16597,0)
 ;;=D59.4^^61^775^184
 ;;^UTILITY(U,$J,358.3,16597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16597,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,16597,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,16597,2)
 ;;=^5002326
